Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +49.35%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +24.17%
#5 Nockchain Nockchain +17.60%
#6 Nillion Nillion +15.06%
#7 FOLKS FOLKS +14.14%
#8 Tutorial Tutorial +13.17%
#9 Humanity Humanity +13.15%
#10 Velvet Velvet +13.00%
Coin of the day
EXOD EXOD
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
E-therapeutics Plc E-therapeutics Plc

E-therapeutics Plc

ETX
Pozycja w akcjach #38866
E-therapeutics Plc, established in 2001 and headquartered in London, UK, is a... E-therapeutics Plc, established in 2001 and headquartered in London, UK, is a drug discovery research company. It employs an advanced computational platform that conducts in silico screening to forecast compounds and biological targets capable of profoundly altering biological systems, drawing insights from its proprietary network models. Additionally, the firm is developing an RNA interference (RNAi) platform aimed at achieving highly specific gene silencing.
Cena akcji
$0.12246314
Ostatnia synchronizacja: 2024-05-08
Kapitalizacja rynkowa
$767.28K
Zmiana (1 dzień)
1.50%
Zmiana (1 rok)
0.00%
Kraj
GB
Handel E-therapeutics Plc (ETX)

Kategoria

Healthcare
Historia stopy dywidendy dla E-therapeutics Plc (ETX)
Stopa dywidendy (TTM) dla E-therapeutics Plc (symbol akcji: ETX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla E-therapeutics Plc (ETX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE